Discovery of coding genetic variants influencing diabetes-related serum biomarkers and their impact on risk of type 2 diabetes.
暂无分享,去创建一个
T. Hansen | O. Pedersen | N. Grarup | T. Jørgensen | I. Brandslund | T. Ahluwalia | T. Lauritzen | A. Linneberg | T. Sparsø | K. Allin | C. Christensen | M. Jørgensen | C. Sandholt | L. Husemoen | M. Rowe | T. Hansen
[1] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[2] P. Poulsen,et al. Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.
[3] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[4] M. Stoffel,et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism , 2001, Nature Genetics.
[5] M. Stoffel,et al. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. , 2001, Diabetes.
[6] Charlotte Glümer,et al. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[7] M. Zonderland,et al. IGF-Binding Protein-1 Levels Are Related to Insulin-Mediated Glucose Disposal and Are a Potential Serum Marker of Insulin Resistance , 2007, Diabetes Care.
[8] Marcia M. Nizzari,et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.
[9] Dolores Corella,et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.
[10] M. Rieder,et al. Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations , 2008, Diabetes.
[11] N. Cook,et al. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. , 2008, American journal of human genetics.
[12] Børge G Nordestgaard,et al. Genetically elevated C-reactive protein and ischemic vascular disease. , 2008, The New England journal of medicine.
[13] Torben Hansen,et al. Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2009, Diabetes Care.
[14] Christian Gieger,et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.
[15] Christian Gieger,et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.
[16] J. Wylie-Rosett,et al. The role of insulin‐like growth factor‐I and its binding proteins in glucose homeostasis and type 2 diabetes , 2009, Diabetes/metabolism research and reviews.
[17] T. Hansen,et al. Validation of a Multimarker Model for Assessing Risk of Type 2 Diabetes from a Five-Year Prospective Study of 6784 Danish People (Inter99) , 2009, Journal of diabetes science and technology.
[18] Shahrul Mt-Isa,et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. , 2009, JAMA.
[19] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[20] J. Shaw,et al. Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.
[21] L. Groop,et al. Genetics of type 2 diabetes. , 2011, Clinical chemistry.
[22] P. Elliott,et al. Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.
[23] N. Yuldasheva,et al. Increasing Circulating IGFBP1 Levels Improves Insulin Sensitivity, Promotes Nitric Oxide Production, Lowers Blood Pressure, and Protects Against Atherosclerosis , 2012, Diabetes.
[24] M. McCarthy,et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes , 2012, Diabetologia.
[25] T. Hansen,et al. Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: Combined results of the Inter99 and Botnia studies , 2012, Diabetes & vascular disease research.
[26] Tanya M. Teslovich,et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.
[27] Yiran Guo,et al. Gene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signals. , 2013, Human molecular genetics.
[28] R. Wahl,et al. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors , 2013, Nature.
[29] B. Nordestgaard,et al. Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individuals , 2014, Diabetologia.
[30] Kari Stefansson,et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes , 2014, Nature Genetics.
[31] S. Bandinelli,et al. Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults. , 2014, Cytokine.
[32] L. Groop,et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes , 2014, Diabetologia.
[33] Thomas Meitinger,et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes , 2014, Nature Genetics.
[34] Matti Pirinen,et al. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins , 2014, Nature Communications.
[35] T. Hansen,et al. Cohort Profile: the Health2006 cohort, research centre for prevention and health. , 2014, International journal of epidemiology.
[36] T. Hansen,et al. Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond , 2014, Diabetologia.
[37] Pierre Fontanillas,et al. Association of exome sequences with plasma C-reactive protein levels in >9000 participants. , 2015, Human molecular genetics.